Larvol Delta - Avalyn-Completes-Successful-Phase-1-Clinical-Trials-of-AP02-its-Novel-Inhaled-Formulation-of-Nintedanib-Preparing-for-Phase-2-Development-in-Idiopathic-Pulmonary-Fibrosis

nintedanib inhaled (AP02) - Avalyn Pharma

https://www.globenewswire.com/news-release/2025/04/01/3053293/0/en/Avalyn-Completes-Successful-Phase-1-Clinical-Trials-of-AP02-its-Novel-Inhaled-Formulation-of-Nintedanib-Preparing-for-Phase-2-Development-in-Idiopathic-Pulmonary-Fibrosis.html

Apr 1, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next